Fibriant

Develops variants of fibrinogen protein for therapeuticapplication

placeLeiden, South Holland, Netherlands calendar_todayFounded 2015 groups9 employees language fibriant.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 1 times.

YearFilings
20201

Investor mix

5 investors on record; lead investors include UNIIQ.

Investor typeCountShare
Venture capital360%
Accelerator & incubator120%
Other / undisclosed120%
Coming soon